Panacea Life Sciences Holdings, Inc. (PLSH) Operating margin 2014–2023
Panacea Life Sciences Holdings, Inc. (PLSH) operating margin by fiscal year — reported operating income divided by reported revenue.
-232.5%FY2023 · since FY2014: -49326.1% → -232.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -232.5% | +114.9 pp |
| FY2022 | -347.4% | -59.1 pp |
| FY2021 | -288.3% | -230.0 pp |
| FY2020 | -58.3% | +3029.2 pp |
| FY2019 | -3087.5% | — |
| FY2015 | -182761.5% | -133435.4 pp |
| FY2014 | -49326.1% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice